Medications are stored on shelves at a pharmacy in Los Angeles, Calif., on May 12, 2025. Eric Thayer/Getty Images
|Updated:
Commentary
President Donald Trump said on Aug. 5 that he will gradually increase tariffs on pharmaceuticals from a small tariff, likely 15 percent, to a high tariff of 250 percent over the next 1.5 years. He told CNBC, “We want pharmaceuticals made in our country.” North of 200 percent would certainly do the trick.
Anders Corr has a bachelor’s/master’s in political science from Yale University (2001) and a doctorate in government from Harvard University (2008). He is a principal at Corr Analytics Inc. and publisher of the Journal of Political Risk, and has conducted extensive research in North America, Europe, and Asia. His latest books are “The Concentration of Power: Institutionalization, Hierarchy, and Hegemony” (2021) and “Great Powers, Grand Strategies: the New Game in the South China Sea” (2018).
